Novel azetidinyl and pyrrolidinyl compounds are ligands of melanocortin-4 receptors and are useful for treating conditions responsive to the modulation of melanocortin-4 receptors such as obesity, diabetes, and sexual dysfunction.
1
新型的
氮杂环丙烷和
吡咯烷化合物是
黑色素皮质激素受体的
配体,并且可用于治疗对
黑色素皮质激素受体调节敏感的疾病,如肥胖、糖尿病和性功能障碍。